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INTRODUCTION 
Genetic engineering offers a novel approach to the development of 
advanced polymeric materials, in particular protein-based materials. 
Biological synthesis provides levels of control of polymer chain architecture 
that cannot yet be attained by current methods of chemical synthesis. In 
addition to employing naturally occurring genetic templates artificial genes 
can be designed to encode completely new materials with customized properties. 
In the present paper we: 1) review the concepts and technology of creating 
protein-based materials by genetic engineering, 2) discuss the merits of 
producing crystalline lamellar proteins by this approach, and 3) review 
progress made by our group in generating such materials by genetic strategies. 
Full descriptions appear elsewhere about the parameters to be considered in 
designing artificial protein genes of this type, the effectiveness of 
different gene construction and expression strategies utilized by us thus far 
and, the specific properties of the various materials derived from these 
efforts (1,2). 
Progress made by other groups involved in developing periodic proteins by 
molecular biological strategies are described in refs. 3-8. The latter 
studies include genetic engineering of artificial silk-like proteins ( 3 , 4 ) ,  
poly-aspartylphenylalanine (5 ) ,  an a/p barrel domain (octarellin; 6), the 
collagen tripeptide GlyProPro (7) and human tropoelastin (8). Advances with 
the silk-like proteins (SLP) have been particularly impressive. In addition 
to producing multi-gram quantities of pure SLP homopolymers, this group has 
successfully generated block copolymers of SLP interspersed with core peptides 
of mammalian elastin and the human fibronectin cell attachment element. While 
publications are still lacking it appears that a nwriber of groups are striving 
to create genetically engineered variants of the repetitive bioadhesive 
proteins produced by mussels and barnacles (9). 
2. BACKGROUND 
2.1 A Role For Genetic Engineering - In Materials Science 
The merits of protein-based materials have been well established for a 
few natural proteins, in particular the silks, elastin, collagen and marine 
bioadhesives. With the advent of genetic engineering technology it is now 
possible to produce these and other proteins with materials potential from 
both natural and artificial genes. In addition to providing an alternative 
means for producing important natural proteins, recombinant DNA technology 
offers the exciting potential of creating completely new proteins with wide 
ranging properties. Synthetic proteins can be designed from first principles 
drawn from the disciplines of protein biochemistry and materials science. At 
least initially artificial proteins would logically feature structural motifs 
that occur in natural proteins, including a-helices, p-pleated sheets and /3- 
turns. Using chemically synthesized genetic material it should be possible to 
engineer entirely new classes of protein-based materials in which natural 
protein elements are joined together in creative and novel ways. The 
properties of these materials could be expanded yet further by subsequent 
chemical or biochemical processing. 
Key benefits of protein-based materials include biocompatibility and 
biodegradability. While such materials can be produced by chemical or 
biological strategies (or a combination of both) biological synthesis offers 
superior control over the strictly chemical methodologies presently available. 
Current chemical methods provide less precise control of molecular 
architecture and also suffer from size and yield limitations. On the other 
hand proteins made biologically will be monodisperse in size and sequence - 
because of the presence of defined start and stop signals in the genetic 
template and the extraordinary specificity and accuracy of the protein 
biosynthetic machinery. In addition, biologically-derived products will be 
pure stereochemically as only L-amino acids are utilized. 
2.2 Genetic Svnthesis of Protein Materials 
A generic approach to developing recombinant protein materials is 
depicted in Figure 1. Concepts from materials science and protein structure 
are used to design a product with specific properties. An appropriate genetic 
template consisting of ribonucleic acid (RNA) is then designed, from the known 
genetic code words (codons) for the amino acid sequence desired. The sequence 
of nucleotides in the messenger RNA template, i.e., mRNA, dictates the DNA 
sequence of the artificial gene. Double-stranded DNA encoding the desired 
protein is chemically synthesized and installed in an appropriate DNA vector 
molecule. It is the role of the vector to ensure that the synthetic coding 
segment is stably maintained and expressed in the recombinant host organism. 
Vector DNA contains information for self-replication, i.e., DNA synthesis, and 
the new coding sequence is flanked by DNA signals for production of mRNA 
(transcription) and decoding of the mRNA to yield the desired protein 
(translation). The host cell currently favored for expression of recombinant 
proteins is the bacterium Escherichia coli. A superior base of molecular 
genetic knowledge exists for E. coli and growth and processing technologies 
are well established for recombinant products expressed by this organism. 
In addition to the actual protein sequence decisions about the design of 
a synthetic protein gene must also include: 1) consideration of host cell 
preference for specific codons (there are from one to six codons per amino 
acid); 2) potential untoward effects on expression (e.g., intramolecular 
folding of mRNA which could impair translation and composition of an early 
mRNA region known to influence activity); and, 3) the strategy for cloning. 
Thus, the final cloning strategy is based on: 1) how the synthetic DNA 
will be joined enzymatically to the cloning and expression vectors; 
2) analysis of the cloned DNA by sequencing - to verify correct construction; 
3) possible re-engineering to create related variant products; 4) the 
expression strategy selected; and 5) the scheme for purifying the product 
protein. Expression is best assured by fusing the artificial coding sequence 
to an upstream gene segment that specifies a portion of a natural protein 
produced at high efficiency by E. coli. In these cases the recombinant 
product will be a bi- or tripartite fusion protein with a foreign peptide 
moiety at the amino end and possibly another at the carboxy terminus. The 
fusion segments can provide stability against damage by host cell proteases. 
These 'tails' can also be exploited in specific purification strategies, for 
example, as ligands in affinity purification. Design considerations also take 
into account the eventual goal of removing fusion peptides, by chemical or 
enzymatic cleavage. Proven approaches include methionine-specific hydrolysis 
with CNBr and cleavage with proteolytic enzymes, both at sites engineered into 
the recombinant protein sequence. 
2.3 The Case For Periodic Proteins 
Our initial efforts in this area have focused on exploring the potential 
for producing recombinant proteins that form crystalline lamellar materials of 
defined thickness and surface function (Fig. 2). These proteins feature 
repeating stem-turn elements predicted to form antiparallel @-pleated sheets. 
The sheets, in turn, are expected to stack to create growth in the third 
dimension. The stem elements correspond to repeating alanine and glycine 
dyads (AlaGly or AG) known to form @-strands in both natural protein (e.g. 
silk fibroin) and poly(AG) produced chemically (4,5). The @-strands are 
interrupted at regular intervals with amino acids anticipated to encourage 
formation of reverse turns (@-turns). The width of the resulting @-sheet and 
thickness of the corresponding lamellar slab is determined by the length of 
the @-stem. The turn residues are predicted to populate the surface of the 
lamellae and thereby define surface functionality. Among the 20 natural amino 
acids there is a broad range of side groups that can be featured at the 
surface, including: alkyl, aryl, -OH, -COOH, -NH2, and -SH moieties. One of 
the major aims of our program is to assess the potential for extending the 
range of synthetic potential through biological incorporation of unnatural 
amino acids, some of which are already known to be utilized by the E. coli 
protein synthetic apparatus. 
Our protein engineering strategy is being evaluated with artificial genes 
that encode sequential peptides of the general sequence: 
where L1, L2 are turn residues. 
3. ENGINEERING OF REPETITIVE PROTEINS 
3.1 Stratenv For Constructing Recombinant Genes 
The feasibilty of our approach was first tested with DNA encoding the 
protein repeats 
Proline is known to disrupt chain folding and both proline and glutamic acid 
were expected to be excluded from the /3-sheet. Additionally, the presence of 
glutamate in the turn sequence would functionalize the hypothetical lamellar 
surface. 
The scheme used to assemble a synthetic DNA fragment encoding peptide 
repeat 3 is shown in Figures 3 and 4. Stepwise, the strategy involved: 1) 
chemical synthesis of double stranded DNA encoding two repeats of 3 ; 2) in 
vitro ligation of this DNA into a plasmid cloning vector; 3) introduction of 
the recombinant vector-insert DNA into E. coli, by transformation; 4) recovery 
of the recombinant plasmid; 5) sequencing of the DNA insert; 6) in vitro 
multimerization of the synthetic DNA fragment, to create larger coding 
sequences; and, 7) cloning of size-selected DNA multimers into an expression 
vector. 
DNA synthesis was carried out with an automated DNA synthesizer. The 
synthetic DNA included three different types of DNA restriction endonuclease 
recognition/cleavage sites - two at the very ends for cloning (EcoRI and 
BamHI) and two flanking restriction sequences for subsequent multimerization 
(BanI). The artificial DNA was inserted into a standard cloning vector, pUC18 
(Fig. 3). Insert DNA from one clone was determined to have the correct 
sequence and this fragment was excised and self-ligated to create a family of 
multimers (Fig. 5 ) .  The population of multimers, ranging upwards of 20 DNA 
monomers was then cloned into a BanI site of a small, high copy vector 
p937.51. Coding sequences inserted into this vector are endowed with flanking 
codons for methionine, making possible eventual cleavage of heterologous 
leader and trailer peptides with cyanogen bromide. Insert DNA was then cloned 
into the expression vector pET3-b (at the BamHI site; Fig. 5). One clone 
encoding 14 DNA repeats of the undecapeptide sequence 3) was selected for 
additional characterization. 
Inserts in the pET3-b vector are expressed by RNA and protein synthesis 
signals from the E. coli bacteriophage T7, in particular from signals of a 
coat protein gene, i.e., gene 10. The T7 virus elements include a very strong 
promoter signal for transcriptional initiation, a transcriptional stop signal, 
and start and stop signals for translation of the gene 10 coat protein; the 
translation signals include; 1) a ribosome binding site (Shine-Dalgarno 
sequence), 2) an important 'leader' segment that encompasses the ribosome 
recognition segment and early mRNA region and, 3) the translational start 
codon AUG, specific for methionine. The fusion specifies a hybrid protein 
with 11 amino acids of the gene 10 protein at the amino terminal end and 19 
amino acids at the carboxy terminus. 
The chromosome of the host bacterium includes a gene for T7 phage RNA 
polymerase, an enzyme that has robust activity and is specific for T7 phage 
promoters; E. coli promoters are ignored. Synthesis of T7 polymerase is 
triggered by addition of a chemical inducer (isopropyl-p-thiogalactoside) 
which inactivates a negative controlling protein, i.e., a repressor. T7 
polymerase is produced and DNA encoding the synthetic protein is transcribed. 
The resulting rnRNA, in turn, is decoded by the bacterial translation 
machinery. 
3.2 Stabilitv of the Artificial Gene and Protein Expression 
Expression plasmids encoding 14 repeats of peptide 3 showed no sign of 
being genetically unstable. Over the course of many cell culturings 
recombinant vector was maintained in the host cells and the insert DNA did not 
undergo any apparent rearrangement. Similar stability has been observed for a 
plasmid containing 54 repeats of peptide 2. Using in vivo radiolabeling 
recombinant proteins 2 and 3 were observed to accumulate at relatively high 
levels following induction of expression; data for repetitive peptide 3 are 
shown in Fig. 6. No material corresponding to putative protein 3 was detected 
in cells lacking recombinant plasmid or for cells harboring vector without the 
artificial DNA insert. Comparisons of protein patterns for both induced and 
non-induced cells indicated that the protein 3 product accumulated to levels 
corresponding to several percent of total cell protein. The recombinant 
protein appears to occur as a single electrophoretic band suggesting that it 
is resistant to damage by cellular proteolytic enzymes. The apparent size of 
the protein is 40 kDa, larger than the 17.2 kDa deduced from the coding 
sequence. Although the basis of the anomalously slow migration is not known 
this behavior has been observed for other proteins featuring related sequence 
elements, including both natural and recombinant silk fibroins (J. Cappello, 
pers. commun.). Similar expression results have been obtained for the peptide 
2 product and this protein also exhibited anomalously slow electrophoretic 
mobility (McGrath et al, submitted). 
A gene encoding another peptide repeat 4 has also been successfully 
assembled and expressed, by the strategy outlined above for the product 3 
protein. This construct features the same @-strand sequence, but a turn of 
two amino acids rather than three. The basic repeat is 
Product corresponding to 36 repeats of 4 has been produced with the 
pET3-b system. This protein also accumulates at levels similar to that 
observed for the product 3 variant and, like proteins 2 and 3, also migrates 
with a lower electrophoretic mobility than predicted. 
4. PROPERTIES OF THE SEQUENTIAL PROTEINS 
Repetitive polymers 2, 3 and 4 have been partially characterized. The 
structures of the recombinant proteins have been verified by: 1) amino acid 
compositional analysis (2,3,4); 2) N-terminal protein sequencing - through 58 
residues (2); 3) matrix-assisted laser desorption mass spectrometry (2,3); 4) 
IH and 13c NMR spectrometry (2,3,4) ; 5) cyanogen bromide cleavage (2,3,4) ; and 
combustion analysis (2,3,4). Taken together, the results from these analyses 
demonstrate that the biosynthetic strategy is sound and effective. While the 
correct proteins were produced there was no evidence that proteins 2 or 3 are 
able to assume the desired @-sheet or ordered lamellar structure of interest. 
Characterization by: 1) x-ray scattering, 2) Fourier transform infrared 
spectrometry and 3) differential scanning calorimetry yielded data indicating 
that both the primary fusion proteins and CNBr cleavage products form 
amorphous glasses at room temperature. 
Preliminary x-ray diffraction patterns have been obtained for protein 4 
precipitated from formic acid. While the diffraction analyses are still in 
progress the early data support the conclusion that sequence 4 polymers form 
@-sheets and that these sheets associate to -form a membrane-like multi- 
lamellar solid. Taken together with computer-assisted modeling these results 
argue that linkers of three amino acids (or alternatively, repeating units 
comprising odd numbers of amino acids) do not allow adjoining @-strand stems 
to align in complete register. The results with repetitive peptide 4 indicate 
that this requirement can be satisfied by at least some two-amino acid turns. 
5. CONCLUSIONS 
We consider that the biological feasibility of our genetic strategy has 
been demonstrated. Artificial genes encoding repetitive peptide sequences 
have been synthesized, assembled and incorporated into host bacterial cells. 
The particular genes constructed thus far are genetically stable and have been 
expressed accurately and with good efficiency by the T7-phage based expression 
vector adopted. Within the limits of the results available recombinant 
proteins containing sequences 2,3 and 4 appear to be resistant to degradation 
by host cell proteolytic enzymes. Finally, first data from x-ray diffraction 
analysis of a sequence 4 polymer have shown that repetitive proteins of the 
type featured here can form highly ordered materials. With the biological 
feasibility of our approach established, at least for the cases described, 
emphasis can now be shifted to specific issues of materials design and 
application. 
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FIGURE LEGENDS 
Figure 1. Production of novel protein-based materials by genetic engineering. 
Figure 2. Structure of repetitive polypeptides designed to form crystalline 
lamellae of pre-determined thickness and surface function. Single polypeptide 
chains consist of repeating units of @-strands and linkers that form reverse 
turns. Chain folding creates anti-parallel @-pleated sheets, which in turn, 
self-associate to generate lamellar crystals. Lamellar thickness is 
determined by the length of the @-stems while surface function is speciifed 
by the amino acids in the @-turn elements. 
Figure 3. Cloning of a synthetic DNA encoding two repeats of peptide sequence 
3. The nucleotide sequence of the artificial DNA monomer is shown replete 
with restriction sites for cloning and subsequent ligation to form high 
molecular weight coding units. The DNA monomer was synthesized chemically and 
incorporated into the E. coli cloning vector pUC18 at the asymmetric EcoRI and 
BamHI restriction sites. Bacteria containing recombinant plasmids were 
identified by blue-white color screening of colonies on medium containing an 
indicator dye - based on insertional inactivation of the gene for @ -  
galactosidase (white). DNA inserts were examined by restriction enzyme 
analysis and DNA sequencing. Monomer DNA was prepared by digestion of hybrid 
plasmids with restriction enzyme BanI. DNA digests were fractionated by 
electrophoresis in gels of agarose or polyacrylamide. 
Figure - 4. Strategy for construction and expression of a synthetic gene 
specifying repetitive polypeptide 3. DNA multimers were produced by in vitro 
ligation of pUC18-derived BanI inserts and cloning into a second vector, 
p937.51 with adjoining sites for BamHI. Inserts from this latter vector were 
cloned into the Bad1 site of expression vector pET3-b. In the final 
construct the artificial DNA segment was fused with the T7 phage gene 10 (410) 
protein coding sequence and upstream signals for 410 transcription and 
translation. Recombinant vector pET3-x was introduced into E. coli strain 
BLZl(DE3)pLysS by transformation. Expression of the target protein is 
achieved by induction of a chromosomal copy of the T7 RNA polymerase gene - by 
addition of isopropyl-/?-D-thiogalactoside (IPTG); IPTG inactivates a repressor 
protein which prevents expression of the polymerase gene. Recombinant protein 
is produced in mid-logarithmic phase cultures and isolated from clarified cell 
lysates by differential precipitation with acetic acid and then ethanol (1,2). 
Figure 5. Electrophoretic pattern of DNA multimers formed in vitro. BanI 
monomer fragments isolated from recombinant pUC18 plasmids were ligated with 
T4 phage DNA ligase and fractionated by polyacrylamide gel electrophoresis. 
Multimers containing upwards of 20 DNA repeats were observed. The repeat size 
is shown at the right. Numbers at the left correspond to DNA size standards 
measured in base pairs. 
Figure 6. Electrophoretic analysis of cloned DNA 3 multimers. The DNA 
fragments shown are from different recombinant p937.51 clones. The number of 
peptide 3 repeats encoded by the cloned DNA fragments is shown at the top. 
The right lane contains DNA size markers; sizes are given at the right edge in 
base pairs. 
Figure 7. Pattern of protein production by transformants containing 
recombinant pET3-b vectors encoding 54 repeats of peptide 2 and 14 repeats of 
peptide 3. Proteins were labeled in vivo with 3~-glycine and fractionated on 
a gel of SDS-polyacrylamide. Lanes 1-4 are negative controls corresponding to 
cells lacking the expression plamid or artificial DNA insert; lanes 5 and 6 
(pET3-27) contains protein from cells with an expression plasmid encoding 54- 
repeats of peptide 2 (from 27 dimeric DNA units; McGrath et al, submitted); 
lanes 7-11 (pET4-14) are protein samples from transformants containing an 
artificial coding unit specifying 14 repeats of peptide 3. Times of sampling 
after induction by IPTG addition are indicated at the top (in min.). The 
pattern shown is a fluorogram prepared by soaking the gel in fluor and 
exposure to x-ray film. Reproduced with permission from Ref. 2, 
Macromolecules. 
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